enGene Holdings Inc Share Price Today: Live Updates & Key Insights

enGene Holdings Inc share price today is $7.24, up -0.07%. The stock opened at $7.16 against the previous close of $7.215, with an intraday high of $7.48 and low of $7.1.

enGene Holdings Inc Share Price Chart

enGene Holdings Inc

us-stock
To Invest in {{usstockname}}
us-stock

enGene Holdings Inc Share Price Performance

$7.24 -0.0007(-0.07%) ENGN at 23 Mar 2026 12:53 PM Biotechnology
Lowest Today 7.1
Highest Today 7.48
Today’s Open 7.16
Prev. Close 7.215
52 Week High 12.25
52 Week Low 2.65
Day’s Range: Low 7.1 High 7.48
52-Week Range: Low 2.65 High 12.25
1 day return -
1 Week return +0.13
1 month return -25.15
3 month return -18.02
6 month return +6.79
1 year return +48.45
3 year return -31.04
5 year return -
10 year return -

enGene Holdings Inc Institutional Holdings

enGene Holdings Inc Market Status

Strong Buy: 4

Buy: 5

Hold: 1

Sell: 0

Strong Sell: 0

enGene Holdings Inc Fundamentals

Market Cap 482.99 M

PB Ratio 1.7203

PE Ratio 0.0

Enterprise Value 241.85 M

Total Assets 221.47 M

Volume 193064

enGene Holdings Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M

Annual Profit FY25:-509000 -0.5M, FY24:null 0.0M, FY23:-175000 -0.2M

Annual Net worth FY25:117302000 117.3M, FY24:55142000 55.1M, FY23:-99917000 -99.9M

Quarterly Revenue Q1/2026:0 0.0M, Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M

Quarterly Profit Q1/2026:-189000 -0.2M, Q4/2025:-171000 -0.2M, Q3/2025:-130000 -0.1M, Q2/2025:-106000 -0.1M, Q1/2025:-102000 -0.1M

Quarterly Net worth Q1/2026:29752000 29.8M, Q4/2025:-37880000 -37.9M, Q3/2025:-28991000 -29.0M, Q2/2025:25815000 25.8M, Q1/2025:-24616000 -24.6M

About enGene Holdings Inc & investment objective

Company Information enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.

Organisation Biotechnology

Employees 81

Industry Biotechnology

CEO Mr. Ronald H. W. Cooper

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

enGene Holdings Inc FAQs

What is the share price of enGene Holdings Inc today?

The current share price of enGene Holdings Inc is $7.24.

Can I buy enGene Holdings Inc shares in India?

Yes, Indian investors can buy enGene Holdings Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy enGene Holdings Inc shares in India?

You can easily invest in enGene Holdings Inc shares from India by:

Can I buy fractional shares of enGene Holdings Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of enGene Holdings Inc?

enGene Holdings Inc has a market cap of $482.99 M.

In which sector does enGene Holdings Inc belong?

enGene Holdings Inc operates in the Biotechnology sector.

What documents are required to invest in enGene Holdings Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of enGene Holdings Inc?

The PE ratio of enGene Holdings Inc is N/A and the PB ratio is 1.72.